ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,426Medicare Part D Prescriptions Filled, Including Refills

Rank: 509 out of 6969

$387K Total Retail Price of All Prescriptions

Rank: 1005 out of 6969

652 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
14% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 652 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,334 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 692 642 1 1
LISINOPRIL 518 464 2 2
LEVOTHYROXINE SODIUM 477 441 3 5
OMEPRAZOLE 353 310 4 6
METOPROLOL TARTRATE 287 252 5 13
ATENOLOL 260 251 6 9
METFORMIN HCL 238 205 7 7
HYDROCHLOROTHIAZIDE 202 186 8 8
HYDROCODONE-ACETAMINOPHEN 192 133 S3 9 3
FUROSEMIDE 177 169 10 10
WARFARIN SODIUM 159 156 11 20
AMLODIPINE BESYLATE 156 154 12 4
ZOLPIDEM TARTRATE 150 140 13 16
EVISTA 142 142 14 118
ATORVASTATIN CALCIUM 136 130 15 11
TRIAMTERENE-HCTZ 126 113 16 58
FLUTICASONE PROPIONATE 119 94 17 24
NAPROXEN 115 93 18 62
BENAZEPRIL HCL 114 106 19 18
LOSARTAN POTASSIUM 105 82 20 12
PROAIR HFA 104 53 21 33
GABAPENTIN 103 77 22 17
IBUPROFEN 99 87 23 29
METOPROLOL SUCCINATE 98 92 24 22
TERAZOSIN HCL 97 92 25 49
TAMSULOSIN HCL 93 92 26 23
POTASSIUM CHLORIDE 85 66 27 30
FENOFIBRATE 85 74 27 63
ALENDRONATE SODIUM 85 77 27 14
TRAZODONE HCL 77 50 30 47
RANITIDINE HCL 74 50 31 46
CITALOPRAM HBR 72 61 32 34
PANTOPRAZOLE SODIUM 70 60 33 31
CARVEDILOL 70 68 33 25
PAROXETINE HCL 67 41 35 65
ALPRAZOLAM 62 62 36 172
PREMARIN 62 62 R 36 156
DOXYCYCLINE HYCLATE 56 48 38 158
SPIRONOLACTONE 55 54 39 102
BENICAR 51 51 40 107
KLOR-CON 8 51 50 40 104
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.